• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    LivaNova PLC - Ordinary Shares (NQ:LIVN)

    63.31 +0.20 (+0.32%)
    Streaming Delayed Price Updated: 10:45 AM EST, Dec 2, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 106,160
    Open 63.19
    Bid (Size) 63.10 (200)
    Ask (Size) 63.52 (100)
    Prev. Close 63.11
    Today's Range 62.32 - 63.58
    52wk Range 32.48 - 64.08
    Shares Outstanding 49,023,767
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Present at Piper Sandler Healthcare Conference in December
    From LivaNova PLC
    Via Business Wire

    Performance

    YTD
    +35.7%
    +35.7%
    1 Month
    +20.4%
    +20.4%
    3 Month
    +11.2%
    +11.2%
    6 Month
    +45.8%
    +45.8%
    1 Year
    +21.1%
    +21.1%

    More News

    Read More
    News headline image
    LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
    From LivaNova PLC
    Via Business Wire
    News headline image
    Earnings Scheduled For November 5, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 6, 2025 ↗
    Via Benzinga
    News headline image
    LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova PLC (NASDAQ:LIVN) Beats Q3 2025 Estimates and Raises Full-Year Guidance ↗
    Via Chartmill
    News headline image
    LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Present at Wolfe Research Healthcare Conference in November
    From LivaNova PLC
    Via Business Wire
    News headline image
    Inspire Medical Systems Soars 3.9% on Groundbreaking Inspire V Clinical Data
    Via MarketMinute
    News headline image
    LivaNova to Announce Third-Quarter 2025 Results
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Appoints Donald Zurbay as a New Director
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Host Investor Day on November 12, 2025
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Launches Essenz Perfusion System in China
    From LivaNova PLC
    Via Business Wire
    News headline image
    Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday ↗
    Via Benzinga
    News headline image
    LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Announce Second-Quarter 2025 Results
    From LivaNova PLC
    Via Business Wire
    News headline image
    CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Present at the Jefferies Global Healthcare Conference
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
    From LivaNova PLC
    Via Business Wire

    Frequently Asked Questions

    Is LivaNova PLC - Ordinary Shares publicly traded?
    Yes, LivaNova PLC - Ordinary Shares is publicly traded.
    What exchange does LivaNova PLC - Ordinary Shares trade on?
    LivaNova PLC - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for LivaNova PLC - Ordinary Shares?
    The ticker symbol for LivaNova PLC - Ordinary Shares is LIVN on the Nasdaq Stock Market
    What is the current price of LivaNova PLC - Ordinary Shares?
    The current price of LivaNova PLC - Ordinary Shares is 63.31
    When was LivaNova PLC - Ordinary Shares last traded?
    The last trade of LivaNova PLC - Ordinary Shares was at 12/02/25 10:45 AM ET
    What is the market capitalization of LivaNova PLC - Ordinary Shares?
    The market capitalization of LivaNova PLC - Ordinary Shares is 3.10B
    How many shares of LivaNova PLC - Ordinary Shares are outstanding?
    LivaNova PLC - Ordinary Shares has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.